SGLT2 Inhibitors and Adverse Events: A Closer Look
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are an emerging class of medications that have become increasingly popular in medication regimens for diabetic patients [...]
Lerma
Tubule or Not Tubule?
It is widely accepted that estimated glomerular filtration rate (eGFR) and urine albumin creatinine ratio have been used as measures in chronic kidney disease (CKD) staging [...]
Pharmacotherapy for the Nephrologist: From Anticoagulants to Anti-hypertensives
A recent AJKD Core Curriculum from Vondracek et al tackles the broad topic of pharmacotherapy. In this piece, the authors discuss basic principles and give a comprehensive [...]
Is New Always Better? Apixaban vs. Warfarin and CKD Progression
Atrial fibrillation (AF) is the most common arrhythmia in patients with chronic kidney disease (CKD), with a prevalence of nearly 24.5%. This is over 2 times higher than [...]
Will You Take the Blue or Red Pill?
Calcium channel blockers (CCBs) and renin-angiotensin-system inhibitors (RASi) are two classes of antihypertensive medications frequently used as initial therapy for [...]
A Patient Behavior Modification to Increase Fluid Intake: The PUSH Trial
With the prevalence of urinary stone disease (USD) nearly doubling over the last 15 years, there has been a concomitant rise in the impact it has on our healthcare system. [...]
Reducing Kidney Function Decline
A recent Core Curriculum in AJKD from Theresa K. Chen and colleagues focuses on one of the most bread-and-butter topics for nephrology—reducing kidney function decline [...]
When the Going Gets Tough in a Pandemic…Optimizing CKRT Resources
SARS-CoV2 is a virus that has shaken the scientific community to its core. As we struggle to catch up to a rapidly evolving global pandemic, it is of utmost importance that [...]
Urgent Peritoneal Dialysis During COVID-19
The coronavirus (SARS-CoV-2) pandemic of 2019 is an unparalleled time in our history with an unprecedented strain on the US healthcare system, particularly in terms of [...]
Icodextrin vs Glucose for the Long Daytime Dwell?
With the Advancing American Kidney Health Initiative (AAKHI), there has been renewed interest in home dialysis, particularly peritoneal dialysis (PD) as a modality of kidney [...]